| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.66e-12 | 20 | 40 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 8.13e-11 | 36 | 40 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD1 RGPD4 RGPD2 ELMOD3 RANBP2 SGSM3 RGPD8 RGPD3 TBCD RGPD5 | 1.41e-10 | 279 | 40 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD1 RGPD4 DENND5B RGPD2 ELMOD3 RANBP2 SGSM3 IPO7 RGPD8 RGPD3 TBCD RGPD5 | 1.85e-10 | 507 | 40 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD1 RGPD4 DENND5B RGPD2 ELMOD3 RANBP2 SGSM3 IPO7 RGPD8 RGPD3 TBCD RGPD5 | 1.85e-10 | 507 | 40 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 6.50e-10 | 50 | 40 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 9.35e-10 | 53 | 40 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.13e-08 | 321 | 40 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | GTPase binding | 3.04e-08 | 360 | 40 | 9 | GO:0051020 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD1 RGPD4 DENND5B RGPD2 ELMOD3 RANBP2 SGSM3 IPO7 RGPD8 RGPD3 TBCD RGPD5 WDTC1 NAIP | 3.12e-07 | 1418 | 40 | 14 | GO:0030234 |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD1 RGPD4 RGPD2 ELMOD3 RANBP2 SGSM3 RGPD8 RGPD3 TBCD RGPD5 | 4.75e-07 | 656 | 40 | 10 | GO:0008047 |
| GeneOntologyMolecularFunction | isomerase activity | 2.14e-06 | 192 | 40 | 6 | GO:0016853 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.25e-05 | 398 | 40 | 7 | GO:0061659 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 6.26e-05 | 512 | 40 | 7 | GO:0019787 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 7.96e-05 | 532 | 40 | 7 | GO:0016755 | |
| GeneOntologyMolecularFunction | molecular function activator activity | RGPD1 RGPD4 RGPD2 ELMOD3 RANBP2 SGSM3 RGPD8 RGPD3 TBCD RGPD5 | 1.20e-04 | 1233 | 40 | 10 | GO:0140677 |
| GeneOntologyMolecularFunction | collagen binding | 5.70e-04 | 81 | 40 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 7.86e-04 | 775 | 40 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | histone binding | 1.90e-03 | 265 | 40 | 4 | GO:0042393 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.00e-15 | 9 | 40 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 4.51e-15 | 20 | 40 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 7.50e-15 | 10 | 40 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 6.10e-14 | 13 | 40 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.07e-13 | 14 | 40 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 9.48e-11 | 38 | 40 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 8.67e-10 | 54 | 40 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 3.28e-09 | 195 | 40 | 8 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 4.16e-09 | 201 | 40 | 8 | GO:0051170 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 4.69e-09 | 71 | 40 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 2.42e-08 | 362 | 40 | 9 | GO:0034504 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 7.01e-08 | 111 | 40 | 6 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 8.66e-08 | 115 | 40 | 6 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 1.17e-07 | 121 | 40 | 6 | GO:0046364 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 1.20e-07 | 310 | 40 | 8 | GO:0005996 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.97e-07 | 132 | 40 | 6 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 2.15e-07 | 134 | 40 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | 3.07e-07 | 646 | 40 | 10 | GO:0005975 | |
| GeneOntologyBiologicalProcess | mRNA transport | 3.43e-07 | 145 | 40 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 3.98e-07 | 244 | 40 | 7 | GO:0006006 | |
| GeneOntologyBiologicalProcess | protein folding | 4.20e-07 | 246 | 40 | 7 | GO:0006457 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 4.32e-07 | 247 | 40 | 7 | GO:0016051 | |
| GeneOntologyBiologicalProcess | nuclear transport | 5.44e-07 | 378 | 40 | 8 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 5.44e-07 | 378 | 40 | 8 | GO:0006913 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.03e-06 | 175 | 40 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.03e-06 | 175 | 40 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 1.10e-06 | 284 | 40 | 7 | GO:0019318 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.14e-06 | 178 | 40 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.43e-06 | 185 | 40 | 6 | GO:0051168 | |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | 1.54e-06 | 434 | 40 | 8 | GO:0062012 | |
| GeneOntologyBiologicalProcess | RNA localization | 3.60e-06 | 217 | 40 | 6 | GO:0006403 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 5.16e-06 | 231 | 40 | 6 | GO:0006109 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | 5.45e-06 | 515 | 40 | 8 | GO:0072594 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 7.93e-06 | 249 | 40 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | protein maturation | 2.07e-05 | 619 | 40 | 8 | GO:0051604 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | 3.88e-05 | 676 | 40 | 8 | GO:0044283 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | 7.34e-05 | 740 | 40 | 8 | GO:0006886 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 1.20e-04 | 405 | 40 | 6 | GO:0033674 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | 1.94e-04 | 1091 | 40 | 9 | GO:0033365 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 3.13e-04 | 686 | 40 | 7 | GO:0043549 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 3.37e-04 | 490 | 40 | 6 | GO:0051347 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 6.75e-04 | 780 | 40 | 7 | GO:0042327 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | 8.43e-04 | 810 | 40 | 7 | GO:0051338 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | 1.36e-03 | 879 | 40 | 7 | GO:0045937 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | 1.36e-03 | 879 | 40 | 7 | GO:0010562 | |
| GeneOntologyBiologicalProcess | intracellular transport | 1.90e-03 | 1496 | 40 | 9 | GO:0046907 | |
| GeneOntologyBiologicalProcess | centrosome localization | 2.10e-03 | 35 | 40 | 2 | GO:0051642 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | 2.13e-03 | 1226 | 40 | 8 | GO:0042325 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 2.22e-03 | 36 | 40 | 2 | GO:0061842 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | 2.47e-03 | 976 | 40 | 7 | GO:0018193 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 9.25e-16 | 8 | 40 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 6.92e-15 | 10 | 40 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 9.84e-14 | 14 | 40 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 6.05e-13 | 18 | 40 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.26e-12 | 20 | 40 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.76e-12 | 21 | 40 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore | 1.52e-11 | 101 | 40 | 8 | GO:0005643 | |
| GeneOntologyCellularComponent | inclusion body | 1.84e-08 | 90 | 40 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear envelope | 8.69e-07 | 560 | 40 | 9 | GO:0005635 | |
| GeneOntologyCellularComponent | nuclear membrane | 3.95e-06 | 349 | 40 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 2.04e-04 | 1377 | 40 | 10 | GO:0140513 | |
| GeneOntologyCellularComponent | organelle envelope | 2.85e-04 | 1435 | 40 | 10 | GO:0031967 | |
| GeneOntologyCellularComponent | transferase complex | 4.07e-04 | 963 | 40 | 8 | GO:1990234 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 8.43e-13 | 16 | 33 | 6 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 2.38e-11 | 26 | 33 | 6 | MP:0012058 | |
| MousePheno | decreased tumor latency | 6.10e-11 | 30 | 33 | 6 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 7.56e-11 | 31 | 33 | 6 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 1.37e-10 | 34 | 33 | 6 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 3.30e-10 | 39 | 33 | 6 | MP:0012128 | |
| MousePheno | aneuploidy | 5.42e-09 | 61 | 33 | 6 | MP:0004024 | |
| MousePheno | increased hepatocellular carcinoma incidence | 1.26e-08 | 70 | 33 | 6 | MP:0003331 | |
| MousePheno | increased lung carcinoma incidence | 2.44e-08 | 78 | 33 | 6 | MP:0008714 | |
| MousePheno | abnormal chromosome number | 4.40e-08 | 86 | 33 | 6 | MP:0004023 | |
| MousePheno | enlarged epididymis | 1.03e-07 | 99 | 33 | 6 | MP:0004931 | |
| MousePheno | increased sarcoma incidence | 1.23e-07 | 102 | 33 | 6 | MP:0002032 | |
| MousePheno | increased lung tumor incidence | 1.64e-07 | 107 | 33 | 6 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 1.64e-07 | 107 | 33 | 6 | MP:0003694 | |
| MousePheno | increased respiratory system tumor incidence | 1.64e-07 | 107 | 33 | 6 | MP:0010298 | |
| MousePheno | increased liver tumor incidence | 2.03e-07 | 111 | 33 | 6 | MP:0008019 | |
| MousePheno | increased hepatobiliary system tumor incidence | 2.03e-07 | 111 | 33 | 6 | MP:0010297 | |
| MousePheno | decreased susceptibility to weight gain | 2.10e-07 | 186 | 33 | 7 | MP:0010182 | |
| MousePheno | abnormal blastocyst hatching | 2.26e-07 | 113 | 33 | 6 | MP:0003693 | |
| MousePheno | abnormal preimplantation embryo morphology | 2.29e-07 | 283 | 33 | 8 | MP:0014137 | |
| MousePheno | abnormal rod electrophysiology | 3.08e-07 | 119 | 33 | 6 | MP:0004021 | |
| MousePheno | abnormal chromosome morphology | 4.32e-07 | 126 | 33 | 6 | MP:0003702 | |
| MousePheno | abnormal mitosis | 4.74e-07 | 128 | 33 | 6 | MP:0004046 | |
| MousePheno | increased incidence of tumors by chemical induction | 8.38e-07 | 141 | 33 | 6 | MP:0004499 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 1.76e-06 | 160 | 33 | 6 | MP:0005659 | |
| MousePheno | abnormal epididymis size | 2.18e-06 | 166 | 33 | 6 | MP:0004926 | |
| MousePheno | abnormal preimplantation embryo development | 2.58e-06 | 171 | 33 | 6 | MP:0009781 | |
| MousePheno | increased incidence of induced tumors | 2.77e-06 | 173 | 33 | 6 | MP:0002021 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 3.77e-06 | 286 | 33 | 7 | MP:0008873 | |
| MousePheno | abnormal cell nucleus morphology | 3.95e-06 | 184 | 33 | 6 | MP:0003111 | |
| MousePheno | increased energy expenditure | 5.69e-06 | 196 | 33 | 6 | MP:0004889 | |
| MousePheno | increased carcinoma incidence | 5.86e-06 | 197 | 33 | 6 | MP:0002038 | |
| MousePheno | abnormal susceptibility to weight gain | 6.28e-06 | 309 | 33 | 7 | MP:0011117 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 6.96e-06 | 203 | 33 | 6 | MP:0011094 | |
| MousePheno | abnormal eye electrophysiology | 1.35e-05 | 228 | 33 | 6 | MP:0005551 | |
| MousePheno | abnormal physiological response to xenobiotic | 1.57e-05 | 662 | 33 | 9 | MP:0008872 | |
| MousePheno | increased malignant tumor incidence | 1.68e-05 | 237 | 33 | 6 | MP:0002018 | |
| MousePheno | embryonic lethality before implantation | 1.89e-05 | 242 | 33 | 6 | MP:0006204 | |
| MousePheno | increased classified tumor incidence | 2.45e-05 | 381 | 33 | 7 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 2.57e-05 | 384 | 33 | 7 | MP:0020188 | |
| MousePheno | increased organ/body region tumor incidence | 3.09e-05 | 395 | 33 | 7 | MP:0010274 | |
| MousePheno | abnormal organ/body region tumor incidence | 3.40e-05 | 401 | 33 | 7 | MP:0013152 | |
| MousePheno | abnormal incidence of induced tumors | 3.44e-05 | 269 | 33 | 6 | MP:0013151 | |
| MousePheno | abnormal epididymis morphology | 3.44e-05 | 269 | 33 | 6 | MP:0002631 | |
| MousePheno | abnormal eye physiology | 6.32e-05 | 606 | 33 | 8 | MP:0005253 | |
| MousePheno | abnormal energy expenditure | 7.99e-05 | 313 | 33 | 6 | MP:0005450 | |
| MousePheno | abnormal tumor incidence | 8.77e-05 | 635 | 33 | 8 | MP:0002019 | |
| MousePheno | abnormal energy homeostasis | 9.34e-05 | 322 | 33 | 6 | MP:0005448 | |
| MousePheno | abnormal tumor susceptibility | 1.03e-04 | 650 | 33 | 8 | MP:0002166 | |
| MousePheno | abnormal cell cycle | 1.74e-04 | 520 | 33 | 7 | MP:0003077 | |
| MousePheno | increased tumor incidence | 1.96e-04 | 530 | 33 | 7 | MP:0002020 | |
| MousePheno | abnormal intracellular organelle morphology | 2.35e-04 | 546 | 33 | 7 | MP:0014239 | |
| MousePheno | neoplasm | 2.70e-04 | 747 | 33 | 8 | MP:0002006 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | 3.37e-04 | 772 | 33 | 8 | MP:0014259 | |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | 3.58e-04 | 779 | 33 | 8 | MP:0014257 | |
| MousePheno | impaired glucose tolerance | 7.99e-04 | 480 | 33 | 6 | MP:0005293 | |
| MousePheno | abnormal blood-brain barrier function | 1.33e-03 | 23 | 33 | 2 | MP:0005167 | |
| MousePheno | decreased myocardial infarct size | 1.57e-03 | 25 | 33 | 2 | MP:0003038 | |
| MousePheno | decreased susceptibility to myocardial ischemic injury | 1.70e-03 | 26 | 33 | 2 | MP:0031216 | |
| MousePheno | abnormal glucose tolerance | 2.06e-03 | 787 | 33 | 7 | MP:0005291 | |
| MousePheno | small testis | 2.65e-03 | 823 | 33 | 7 | MP:0001147 | |
| Domain | Ran_BP1 | 9.33e-17 | 12 | 40 | 7 | PF00638 | |
| Domain | RANBD1 | 9.33e-17 | 12 | 40 | 7 | PS50196 | |
| Domain | RanBD | 2.02e-16 | 13 | 40 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 2.02e-16 | 13 | 40 | 7 | IPR000156 | |
| Domain | GRIP | 2.99e-14 | 11 | 40 | 6 | PF01465 | |
| Domain | Grip | 2.99e-14 | 11 | 40 | 6 | SM00755 | |
| Domain | GRIP_dom | 5.96e-14 | 12 | 40 | 6 | IPR000237 | |
| Domain | GRIP | 5.96e-14 | 12 | 40 | 6 | PS50913 | |
| Domain | GCC2_Rab_bind | 7.28e-13 | 7 | 40 | 5 | IPR032023 | |
| Domain | Rab_bind | 7.28e-13 | 7 | 40 | 5 | PF16704 | |
| Domain | - | 8.69e-12 | 10 | 40 | 5 | 1.10.220.60 | |
| Domain | TPR-contain_dom | 8.88e-10 | 150 | 40 | 8 | IPR013026 | |
| Domain | TPR | 1.89e-09 | 165 | 40 | 8 | PS50005 | |
| Domain | TPR_REGION | 1.89e-09 | 165 | 40 | 8 | PS50293 | |
| Domain | TPR | 9.82e-09 | 129 | 40 | 7 | SM00028 | |
| Domain | TPR_repeat | 1.21e-08 | 133 | 40 | 7 | IPR019734 | |
| Domain | TPR-like_helical_dom | 2.84e-08 | 233 | 40 | 8 | IPR011990 | |
| Domain | - | 2.54e-07 | 207 | 40 | 7 | 1.25.40.10 | |
| Domain | TPR_1 | 1.34e-06 | 90 | 40 | 5 | PF00515 | |
| Domain | TPR_1 | 1.34e-06 | 90 | 40 | 5 | IPR001440 | |
| Domain | PH_dom-like | 2.78e-06 | 426 | 40 | 8 | IPR011993 | |
| Domain | - | 1.72e-05 | 391 | 40 | 7 | 2.30.29.30 | |
| Domain | Carb_kinase_FGGY_C | 4.45e-05 | 5 | 40 | 2 | IPR018485 | |
| Domain | FGGY_C | 6.67e-05 | 6 | 40 | 2 | PF02782 | |
| Domain | Carb_kinase_FGGY_N | 6.67e-05 | 6 | 40 | 2 | IPR018484 | |
| Domain | Carb_kinase_FGGY | 9.33e-05 | 7 | 40 | 2 | IPR000577 | |
| Domain | FGGY_N | 9.33e-05 | 7 | 40 | 2 | PF00370 | |
| Domain | RUN | 6.70e-04 | 18 | 40 | 2 | SM00593 | |
| Domain | RUN | 7.47e-04 | 19 | 40 | 2 | PS50826 | |
| Domain | Run_dom | 7.47e-04 | 19 | 40 | 2 | IPR004012 | |
| Domain | RUN | 7.47e-04 | 19 | 40 | 2 | PF02759 | |
| Domain | NACHT | 1.10e-03 | 23 | 40 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 1.10e-03 | 23 | 40 | 2 | IPR007111 | |
| Domain | ARM-type_fold | 5.82e-03 | 339 | 40 | 4 | IPR016024 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 7.96e-13 | 18 | 29 | 6 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.60e-10 | 40 | 29 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.87e-10 | 41 | 29 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.18e-10 | 42 | 29 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.53e-10 | 43 | 29 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.42e-10 | 47 | 29 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 5.74e-10 | 49 | 29 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 6.52e-10 | 50 | 29 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 7.38e-10 | 51 | 29 | 6 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.18e-09 | 55 | 29 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.64e-09 | 58 | 29 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.64e-09 | 58 | 29 | 6 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.32e-09 | 65 | 29 | 6 | MM15147 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 6.02e-09 | 129 | 29 | 7 | MM14894 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 6.76e-09 | 73 | 29 | 6 | MM14948 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.12e-08 | 141 | 29 | 7 | MM15266 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.37e-08 | 82 | 29 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.59e-08 | 84 | 29 | 6 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.83e-08 | 86 | 29 | 6 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.76e-08 | 92 | 29 | 6 | MM14951 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 4.56e-08 | 100 | 29 | 6 | MM14561 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 9.78e-08 | 193 | 29 | 7 | MM14890 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.00e-07 | 114 | 29 | 6 | MM15361 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.17e-07 | 117 | 29 | 6 | MM15387 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.34e-07 | 202 | 29 | 7 | MM15362 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 3.63e-07 | 234 | 29 | 7 | MM14898 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 6.83e-07 | 257 | 29 | 7 | MM14755 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 9.76e-07 | 271 | 29 | 7 | MM15406 | |
| Pathway | REACTOME_SUMOYLATION | 1.03e-06 | 169 | 29 | 6 | MM14919 | |
| Pathway | REACTOME_M_PHASE | 1.03e-05 | 387 | 29 | 7 | MM15364 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.56e-05 | 271 | 29 | 6 | MM15388 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.77e-05 | 277 | 29 | 6 | MM15414 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | RGPD1 RGPD4 RGPD2 RANBP2 SPARCL1 NEURL2 TUBA8 RGPD8 MYSM1 RGPD3 WDTC1 | 5.28e-05 | 1389 | 29 | 11 | MM15307 |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 5.71e-05 | 505 | 29 | 7 | MM15548 | |
| Pathway | REACTOME_CELL_CYCLE | 1.73e-04 | 603 | 29 | 7 | MM14635 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 2.73e-04 | 649 | 29 | 7 | MM15690 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 1.01e-03 | 23 | 29 | 2 | M19135 | |
| Pathway | WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY | 1.10e-03 | 24 | 29 | 2 | M39399 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.32e-03 | 612 | 29 | 6 | MM15547 | |
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 21205196 | ||
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 18949001 | ||
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 25187515 | ||
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 9037092 | ||
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 8603673 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.28e-17 | 7 | 41 | 6 | 15710750 | |
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 26632511 | ||
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 24403063 | ||
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.28e-17 | 7 | 41 | 6 | 11353387 | |
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 30944974 | ||
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 38838144 | ||
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.28e-17 | 7 | 41 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.28e-17 | 7 | 41 | 6 | 17372272 | |
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 38657106 | ||
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 12191015 | ||
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 22821000 | ||
| Pubmed | 1.28e-17 | 7 | 41 | 6 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 5.12e-17 | 8 | 41 | 6 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 5.12e-17 | 8 | 41 | 6 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 5.12e-17 | 8 | 41 | 6 | 28745977 | |
| Pubmed | 5.12e-17 | 8 | 41 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 5.12e-17 | 8 | 41 | 6 | 21310149 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.53e-16 | 9 | 41 | 6 | 18394993 | |
| Pubmed | 1.53e-16 | 9 | 41 | 6 | 11553612 | ||
| Pubmed | 1.53e-16 | 9 | 41 | 6 | 10601307 | ||
| Pubmed | 1.53e-16 | 9 | 41 | 6 | 9733766 | ||
| Pubmed | 1.53e-16 | 9 | 41 | 6 | 28100513 | ||
| Pubmed | 1.53e-16 | 9 | 41 | 6 | 28877029 | ||
| Pubmed | 1.53e-16 | 9 | 41 | 6 | 17887960 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 3.83e-16 | 10 | 41 | 6 | 8857542 | |
| Pubmed | 3.83e-16 | 10 | 41 | 6 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 3.83e-16 | 10 | 41 | 6 | 16332688 | |
| Pubmed | 3.83e-16 | 10 | 41 | 6 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 8.42e-16 | 11 | 41 | 6 | 35771867 | |
| Pubmed | 8.42e-16 | 11 | 41 | 6 | 17069463 | ||
| Pubmed | 8.42e-16 | 11 | 41 | 6 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 3.12e-15 | 13 | 41 | 6 | 31427429 | |
| Pubmed | 9.09e-15 | 15 | 41 | 6 | 14697343 | ||
| Pubmed | 1.35e-13 | 22 | 41 | 6 | 27717094 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 4.91e-12 | 38 | 41 | 6 | 12791264 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 5.51e-10 | 153 | 41 | 7 | 26365490 | |
| Pubmed | 8.03e-10 | 86 | 41 | 6 | 37253089 | ||
| Pubmed | 1.89e-09 | 99 | 41 | 6 | 27746211 | ||
| Pubmed | 5.88e-09 | 215 | 41 | 7 | 35973513 | ||
| Pubmed | 6.08e-09 | 4 | 41 | 3 | 9480752 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.23e-08 | 135 | 41 | 6 | 31077711 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.97e-08 | 146 | 41 | 6 | 23892456 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 4.23e-08 | 442 | 41 | 8 | 15815621 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 6.57e-08 | 665 | 41 | 9 | 30457570 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.40e-07 | 370 | 41 | 7 | 22922362 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 2.62e-07 | 226 | 41 | 6 | 37839992 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.98e-07 | 231 | 41 | 6 | 16452087 | |
| Pubmed | 5.45e-07 | 418 | 41 | 7 | 34709266 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 6.89e-07 | 1155 | 41 | 10 | 20360068 | |
| Pubmed | Importin 7 and Nup358 promote nuclear import of the protein component of human telomerase. | 1.36e-06 | 2 | 41 | 2 | 24586428 | |
| Pubmed | 5.47e-06 | 844 | 41 | 8 | 25963833 | ||
| Pubmed | 5.72e-06 | 1139 | 41 | 9 | 36417873 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 19933990 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 9.69e-06 | 647 | 41 | 7 | 26618866 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 1.26e-05 | 1257 | 41 | 9 | 37317656 | |
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 20551517 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 12082590 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.62e-04 | 701 | 41 | 6 | 30196744 | |
| Pubmed | ERK1 and ERK2 regulate chondrocyte terminal differentiation during endochondral bone formation. | 1.82e-04 | 17 | 41 | 2 | 25401279 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.91e-04 | 271 | 41 | 4 | 32433965 | |
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 2.95e-04 | 272 | 41 | 4 | 18187620 | |
| Pubmed | 4.33e-04 | 26 | 41 | 2 | 23181366 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 4.62e-04 | 853 | 41 | 6 | 28718761 | |
| Pubmed | 5.78e-04 | 30 | 41 | 2 | 31065682 | ||
| Pubmed | 6.25e-04 | 332 | 41 | 4 | 25693804 | ||
| Pubmed | 6.87e-04 | 146 | 41 | 3 | 27068509 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 8.16e-04 | 626 | 41 | 5 | 33644029 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 8.19e-04 | 357 | 41 | 4 | 37059091 | |
| Pubmed | 8.72e-04 | 963 | 41 | 6 | 28671696 | ||
| Interaction | RGPD4 interactions | 1.16e-14 | 22 | 40 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 6.01e-14 | 27 | 40 | 7 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 4.14e-12 | 47 | 40 | 7 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 5.63e-12 | 49 | 40 | 7 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 1.14e-10 | 74 | 40 | 7 | int:RGPD8 | |
| Interaction | NPIPB6 interactions | 2.00e-10 | 18 | 40 | 5 | int:NPIPB6 | |
| Interaction | RGPD5 interactions | 7.31e-10 | 96 | 40 | 7 | int:RGPD5 | |
| Interaction | RAN interactions | 3.56e-06 | 475 | 40 | 8 | int:RAN | |
| Interaction | RANBP2 interactions | 6.26e-06 | 361 | 40 | 7 | int:RANBP2 | |
| Interaction | AKIRIN2 interactions | 1.38e-05 | 74 | 40 | 4 | int:AKIRIN2 | |
| Interaction | ESRP1 interactions | 1.62e-05 | 77 | 40 | 4 | int:ESRP1 | |
| Interaction | NEMP1 interactions | 2.88e-05 | 89 | 40 | 4 | int:NEMP1 | |
| Interaction | RCC1 interactions | 4.65e-05 | 201 | 40 | 5 | int:RCC1 | |
| Interaction | KLC3 interactions | 6.60e-05 | 110 | 40 | 4 | int:KLC3 | |
| Interaction | TSKS interactions | 6.80e-05 | 40 | 40 | 3 | int:TSKS | |
| Interaction | MLNR interactions | 3.32e-04 | 68 | 40 | 3 | int:MLNR | |
| Cytoband | 2p11.2 | 2.65e-05 | 64 | 41 | 3 | 2p11.2 | |
| Cytoband | 2q13 | 3.18e-05 | 68 | 41 | 3 | 2q13 | |
| Cytoband | 1p32.1 | 3.49e-05 | 10 | 41 | 2 | 1p32.1 | |
| Cytoband | 2q12.3 | 1.05e-04 | 17 | 41 | 2 | 2q12.3 | |
| Cytoband | 4q31.3 | 3.56e-04 | 31 | 41 | 2 | 4q31.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | 9.22e-04 | 213 | 41 | 3 | chr2p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q13 | 1.29e-03 | 59 | 41 | 2 | chr2q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q12 | 2.47e-03 | 82 | 41 | 2 | chr2q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 6.44e-03 | 134 | 41 | 2 | chr7p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p32 | 8.52e-03 | 155 | 41 | 2 | chr1p32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q31 | 9.49e-03 | 164 | 41 | 2 | chr4q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q14 | 9.60e-03 | 165 | 41 | 2 | chr2q14 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.85e-12 | 115 | 28 | 8 | 769 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.07e-11 | 33 | 41 | 6 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 5.84e-11 | 43 | 41 | 6 | MM3857 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D | RGPD1 RGPD4 TPMT RGPD2 ELMOD3 RANBP2 RGPD8 MTUS1 PCCA RGPD3 TBCD CCDC85B | 6.78e-09 | 888 | 41 | 12 | MM1315 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 3.19e-07 | 435 | 41 | 8 | MM1221 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 7.99e-06 | 474 | 41 | 7 | M40991 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_TREG_CELL | 3.37e-05 | 40 | 41 | 3 | M45776 | |
| ToppCell | facs-SCAT-Fat-3m-Myeloid-myeloid_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 166 | 41 | 4 | 8395c74db8e4e54af97a3f2b75cb75171140ec31 | |
| ToppCell | facs-SCAT-Fat-3m-Myeloid|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 166 | 41 | 4 | 76807edc5620514b53a14be354b84c54c112b8f9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.63e-05 | 166 | 41 | 4 | b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9 | |
| ToppCell | facs-SCAT-Fat-3m-Myeloid-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 166 | 41 | 4 | 645b842b94b8d2f4b26c2623f8589f56bd782c26 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 173 | 41 | 4 | 054f64462b648ba6b4b28b48c716dc01b2ddd790 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 173 | 41 | 4 | 9a8fec9a08bb61456a4ea43ae1316bd3e197a773 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-05 | 180 | 41 | 4 | efc4c5a4dea456527526bbfd88cf70d803893671 | |
| ToppCell | BAL-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-05 | 183 | 41 | 4 | 8e9d45c96b44558158e3d59613f64a73d5390c19 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-05 | 183 | 41 | 4 | 0408d991ddb639594b45d5cb2432dd29289167b1 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-05 | 183 | 41 | 4 | 79f05b8a967124d831b0baef137e30659f5917a7 | |
| ToppCell | BAL-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.44e-05 | 184 | 41 | 4 | 7331535d469453a5264dcb0270a97f63d3b55201 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.44e-05 | 184 | 41 | 4 | 92202e1cd0bba1ce4b061ebcb8a2af5bb590542a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-05 | 184 | 41 | 4 | b45b1fdba13c8ed2a04a4fb3b62d8ad92785c768 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.44e-05 | 184 | 41 | 4 | 337e38a6b2b6770cc992d88b006829f194841b10 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 189 | 41 | 4 | 0c612ff5f882f2d8ec744a347780bbbe7cc471bd | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.71e-05 | 189 | 41 | 4 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 189 | 41 | 4 | bc8949bd4f425ed36e2c05e653c94cb1593c5bee | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 2.71e-05 | 189 | 41 | 4 | aac79c41ce7acba722c45c016b2c6997fb772a96 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.76e-05 | 190 | 41 | 4 | 96c6078619e85f630c9754aca5d6066433e22836 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-05 | 192 | 41 | 4 | eafead22bba48ac5ee568faa8946c444445c1034 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-05 | 195 | 41 | 4 | ccfb80e3bfdf5304fa798e0a47b473955ecc0c6d | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 3.06e-05 | 195 | 41 | 4 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-05 | 196 | 41 | 4 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|normal_Lung / Location, Cell class and cell subclass | 3.12e-05 | 196 | 41 | 4 | 4d3a3264b3d781139899448cde3b7a4f214ca14d | |
| ToppCell | (7)_Macrophage|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.12e-05 | 196 | 41 | 4 | f1c822860d2a0bae84b0263b0151185756423e0f | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 41 | 4 | 61bda9b5102fdbce902bb976d1aa62f2c799d2fb | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.18e-05 | 197 | 41 | 4 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-05 | 197 | 41 | 4 | c29ed0e706999d4c2b93e6e3bf46c42aeceb4813 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.18e-05 | 197 | 41 | 4 | f45a93b5ad80a16b760acbaa6467648ffc05a0d3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.18e-05 | 197 | 41 | 4 | a6aa5991d566c28440f7e24a30933e69669064f2 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.24e-05 | 198 | 41 | 4 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Erythrophagocytic_macrophages|Liver / Manually curated celltypes from each tissue | 3.31e-05 | 199 | 41 | 4 | 600afac424416268766fc5c051d4c62ab9eef5de | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.31e-05 | 199 | 41 | 4 | cbd423c31d75f6d2f5ae85d2241641fcbe630b81 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.31e-05 | 199 | 41 | 4 | 980b10b81ee9dc952e3be25bd294201ce5a4ca8b | |
| ToppCell | 10x5'-Liver-Myeloid_Mac|Liver / Manually curated celltypes from each tissue | 3.31e-05 | 199 | 41 | 4 | aed138ee879e4e625f177c5bfe0f857a335eb6f2 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 3.31e-05 | 199 | 41 | 4 | c051cc3e42cfa2ec09fd8dae1172af350bb2dfcb | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-05 | 199 | 41 | 4 | 258d59cf811bf1668ffbb5f18f961021f660de62 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.37e-05 | 200 | 41 | 4 | cd3c638961144a2fc91c437a173cc37c7452fa74 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 1a080564de59abd59d3208a73441b6346e1c7cd8 | |
| ToppCell | COVID-19-Fibroblasts-Vascular_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 3.37e-05 | 200 | 41 | 4 | c7f82196a0768ad96b1df8b8915bc541fb118a76 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-05 | 200 | 41 | 4 | 1438b84096de9b4abe9e6213caa07f6bdff67358 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tumor_ECs|Endothelial_cells / Location, Cell class and cell subclass | 3.37e-05 | 200 | 41 | 4 | 9c1b30fa96565515a7160f439cadcd51482c41e9 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-04 | 22 | 41 | 2 | 124067c169b11131084e634b8c29fd855b8eb231 | |
| ToppCell | TCGA-Thymus|World / Sample_Type by Project: Shred V9 | 2.07e-04 | 125 | 41 | 3 | 109857418118020d35f05a5eb8a25bb7e3d8ed2a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 130 | 41 | 3 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-04 | 133 | 41 | 3 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-04 | 134 | 41 | 3 | 932b7dd5781b730dcd2ffe43f6e142e3f8630f67 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.53e-04 | 134 | 41 | 3 | b5466759285b4973850afb2e1be7c1d25f1c7927 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.88e-04 | 140 | 41 | 3 | 72c272f44e5600b3037c1dbf9d3a4669a35588d8 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 2.94e-04 | 141 | 41 | 3 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.13e-04 | 144 | 41 | 3 | 748f4efc59f7afbce6c497524f36d852b8b1d637 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-04 | 145 | 41 | 3 | ab0e254a8d01021619853a6c175f620ccef217d8 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-04 | 145 | 41 | 3 | 2beb4ea3838796c580076ab7769de877a3a0552c | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-04 | 146 | 41 | 3 | df865558d1843f3857ebd1529cebc540d3554c59 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-04 | 150 | 41 | 3 | a003cbaf25a1b5ad4d361dcf162afe0c4b8b78f8 | |
| ToppCell | facs-Trachea-nan-24m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 151 | 41 | 3 | 26fd55efb647c41436416d45952ee97b050e632c | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 152 | 41 | 3 | f717aae4882e9b67e5e40f4ef5b0d35f74a89165 | |
| ToppCell | Control-Myeloid-Neutrophils-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-04 | 153 | 41 | 3 | e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-04 | 153 | 41 | 3 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | Control-Myeloid-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-04 | 153 | 41 | 3 | c33d63b2d1a220bc428e776b157b23faa43ea8ca | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 3.88e-04 | 155 | 41 | 3 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | ASK452-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.95e-04 | 32 | 41 | 2 | fd0777da59e8ac3e0f766071977cb169d058e5ae | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.96e-04 | 156 | 41 | 3 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | facs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 156 | 41 | 3 | f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 156 | 41 | 3 | da4f35353a84d919e683554932f110e29568df33 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 156 | 41 | 3 | f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | 3cffedafff31efb5b3259194157b54a768367459 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | f87e867a394b0453ebd92c592e80450caf5902cb | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | 042129d1b514dc4ed8a5f45b52d9c73cf4807636 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.03e-04 | 157 | 41 | 3 | 188d2f85babcd4eefe20e7a392d851b2e1185bab | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | c3451b33780499fd62672e7cd71c7e8cb6ccc2c5 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | 92cd58b62e46b93f90e05657fd201404ccae6ddb | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.11e-04 | 158 | 41 | 3 | 9a6d9b541446a6aa9f8ed040b330dbb5c6447076 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.11e-04 | 158 | 41 | 3 | 2438713d2a7e32c647ab3384237ed614f4ec8fec | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 160 | 41 | 3 | bd5fa7959bfe81011b8d798535b73ea1eee008b3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.34e-04 | 161 | 41 | 3 | 78cb72c462167021195917a06052bcdc367ad890 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.34e-04 | 161 | 41 | 3 | 06e7becfd11d6ef1a45a9cfdfcb40b812600038e | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.34e-04 | 161 | 41 | 3 | d1f2e5245c7c247b684f48f9f877e149a3ee7c06 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 162 | 41 | 3 | c399b9e4854916a59f5cae2d8dbf19660f8759be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 162 | 41 | 3 | a291248b693c771845174393934a782f1d8bd7ce | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.50e-04 | 163 | 41 | 3 | 466c8129852a5b16cd9fcc6b79e799abc21bb21a | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 163 | 41 | 3 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | droplet-Fat-Gat-18m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 163 | 41 | 3 | 3d12a8ca97005308403a3ab136af483ab25f9b0e | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | 0e424a69999eee13d27c4ff4f4ba3df64d3c2bda | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | 4e0133a7f80cf6bd3d70f72ee26360df5f80ab32 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | 4ab1a7d5379a633c3f61af1c8c2df93b6961d9cf | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.58e-04 | 164 | 41 | 3 | f0499e6c1b17c4df72b18b294e3b53ef723da2ac | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | fe9ecdd7a6cbaf910f42654eba75f79bea740a00 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-04 | 165 | 41 | 3 | 082f62f759a0b16ab56fad6dd4c4dd70b4f18a5c | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-04 | 165 | 41 | 3 | 651d40eadb1b34de618af94c167f43635729d43f | |
| ToppCell | facs-Heart-LA-24m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | 2c931d593e189127c31adaf36a3df81d8287bb53 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | cd22d4222bc748942ed570a8978cb015e3b55388 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | 7f8b4cf63c3e292ae421f111edaa4572717f4db1 | |
| ToppCell | facs-Heart-LA-24m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | 9e7a9cb7beeb7015fcaa476a4902883dee99e8c0 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.74e-04 | 166 | 41 | 3 | 7be2b5c62e2be3437ea50b9a473cf9fc7f05e0b1 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-interstitial_macrophage|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.74e-04 | 166 | 41 | 3 | 8418b191e7f16cb39301df3ddbfb1bab6c0632d6 | |
| ToppCell | facs-Heart-LA-24m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | 2a3c396deb068066b8c2f85ddd2fa52629776bcd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | 0868f45d8d39ad39b5cee5e81ac3dd4dc512775d | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | 5f6031420bffb1813fe4989021f9f3a54a7243b0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-04 | 167 | 41 | 3 | 2dc3de562a26077cb76855b725cf278a272d3276 | |
| Computational | Nuclear pore complex. | 3.16e-04 | 17 | 17 | 2 | MODULE_352 | |
| Disease | alcohol and nicotine codependence | 1.12e-04 | 13 | 36 | 2 | EFO_0004776 | |
| Disease | intracranial aneurysm (is_marker_for) | 1.30e-04 | 14 | 36 | 2 | DOID:10941 (is_marker_for) | |
| Disease | carotid artery disease (is_marker_for) | 2.44e-04 | 19 | 36 | 2 | DOID:3407 (is_marker_for) | |
| Disease | chromatid-type aberration frequency | 4.62e-04 | 26 | 36 | 2 | EFO_0009862 | |
| Disease | obstructive sleep apnea (is_marker_for) | 5.76e-04 | 29 | 36 | 2 | DOID:0050848 (is_marker_for) | |
| Disease | pulmonary hypertension (is_implicated_in) | 6.16e-04 | 30 | 36 | 2 | DOID:6432 (is_implicated_in) | |
| Disease | myocardial infarction (is_marker_for) | 7.46e-04 | 33 | 36 | 2 | DOID:5844 (is_marker_for) | |
| Disease | Paroxysmal atrial fibrillation | 9.11e-04 | 156 | 36 | 3 | C0235480 | |
| Disease | familial atrial fibrillation | 9.11e-04 | 156 | 36 | 3 | C3468561 | |
| Disease | Persistent atrial fibrillation | 9.11e-04 | 156 | 36 | 3 | C2585653 | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 9.38e-04 | 37 | 36 | 2 | DOID:0050865 (is_marker_for) | |
| Disease | Atrial Fibrillation | 9.80e-04 | 160 | 36 | 3 | C0004238 | |
| Disease | end stage renal disease (is_marker_for) | 1.45e-03 | 46 | 36 | 2 | DOID:783 (is_marker_for) | |
| Disease | multiple sclerosis (is_marker_for) | 1.64e-03 | 49 | 36 | 2 | DOID:2377 (is_marker_for) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 1.71e-03 | 50 | 36 | 2 | DOID:3770 (biomarker_via_orthology) | |
| Disease | diabetic retinopathy (is_implicated_in) | 1.71e-03 | 50 | 36 | 2 | DOID:8947 (is_implicated_in) | |
| Disease | susceptibility to common cold measurement | 1.99e-03 | 54 | 36 | 2 | EFO_0008417 | |
| Disease | diabetic retinopathy (is_marker_for) | 1.99e-03 | 54 | 36 | 2 | DOID:8947 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CLEKWQEGDDPLDDH | 321 | Q13075 | |
| HGICDWKQDREDDFD | 406 | Q8IUX8 | |
| KFDCALHGNHWEDLG | 186 | Q96FG2 | |
| EDLGGCWQKLAELEG | 111 | Q15834 | |
| DDKEGHLVCRIGDWL | 286 | P49761 | |
| CDGHWLLAEDRLFGL | 46 | Q8WXS4 | |
| FDSHKGFWCQLLEEG | 801 | O95803 | |
| CEGEDGWNKLFDLIQ | 141 | P49792 | |
| CEGEDGWNKLFDLIQ | 141 | Q99666 | |
| CEGEDGWNKLFDLIQ | 141 | O14715 | |
| DAHFDDDELWSLGKG | 201 | P14780 | |
| HSLEWDKQLCEFFGI | 211 | Q14409 | |
| ENEELLWKLHNGDLC | 1226 | Q9ULD2 | |
| WLNDVDCFLGLHDRK | 821 | O95373 | |
| WDSCLEHNLRPFGKD | 86 | Q14D04 | |
| GDKHGNALWLNEREC | 276 | P05165 | |
| FLVEIEEKELGWCGH | 66 | Q9BR09 | |
| LGLHKDFDQWDCLIE | 396 | Q13093 | |
| CEGEDGWNKLFDLIQ | 141 | A6NKT7 | |
| LEEKGEEWHCLLKDD | 261 | Q05DH4 | |
| NLREICWDKAGHFFD | 156 | Q96C11 | |
| GHDNSGLLAKWLVDC | 996 | Q6ZUT9 | |
| HSLEWDKQLCEFFGI | 211 | P32189 | |
| PLGWSGKHCELNIDE | 1166 | P82279 | |
| HCPDTGKDIWNLLFD | 286 | Q96ER3 | |
| GKDIWNLLFDLVCHE | 291 | Q96ER3 | |
| KEHLLDCEGEDGWNK | 126 | P0DJD0 | |
| CEGEDGWNKLFDLIQ | 141 | Q7Z3J3 | |
| RDWDDHGAGEKLPCL | 156 | Q8N3T6 | |
| HLLDCEGEDGWNKLF | 136 | P0DJD1 | |
| SQKDEHCWVGELNGL | 511 | Q96HU1 | |
| WDGDHYDALRDCLKA | 411 | Q8N5D0 | |
| KDWTGNELHECNELG | 41 | A8K554 | |
| VEDFGNAWKLHGDCQ | 546 | P04275 | |
| AFDGLLELWDLQHGC | 1736 | Q99973 | |
| EWGHCFGIKEEDIDE | 646 | Q14515 | |
| LGHNDFKCSNGWLDR | 121 | Q8IY51 | |
| ETDKAWHGGCLALAE | 411 | Q9BTW9 | |
| VDHFWGLDDDGDLKG | 146 | O94901 | |
| DAFEERHKSWGIDCL | 221 | P51580 | |
| AAGPHEAFNKLWELC | 41 | Q6P9G9 | |
| WELFCLEHGIQADGT | 21 | Q9NY65 | |
| NWCDAKDLEGQTFEH | 511 | Q5VVJ2 |